Bringing the Oncology Community Together

Lung Cancer

OncLive TV - A Network of Your Peers

Dr. Perez-Soler on Treatment Options for NSCLC

Dr. Belani Discusses NSCLC Adjuvant Therapy

Dr. Langer Discusses the PARAMOUNT Study

Dr. Yung Discusses Forming a Multidisciplinary Team

Dr. Mills Gives Examples of Unexpected Drug Responses

>>> More Lung Cancer Videos

Radiation Therapy After Surgery Shows No Survival Benefit for Elderly Lung Cancer Patients

Many older patients with stage III lung cancer who received radiation therapy fared no better than those who did not receive radiation therapy.

> Web Exclusives

Changing Paradigms for NSCLC in Personalized Therapy Era

With the discovery of mutation drivers for NSCLC--including EGFR, KRAS, and EMLA 4-ALK--targeted therapies directed to those mutations are beginning to make a difference.

Oncology & Biotech News > Conference Highlights

Continuing Chemotherapy to Near Death Offers No Benefits in Older Patients With Advanced Lung Cancer

An aggressive approach to care involving the continuation of chemotherapy within 2 weeks of death does not improve survival in elderly patients with metastatic NSCLC.

Oncology & Biotech News > Clinical Trial Reports

SCLC on the Wane, but Difficult to Treat

Patients with limited and extensive SCLC show incremental gains with different treatment strategies but so far novel agents have failed to make a difference in outcomes.

Oncology & Biotech News > Conference Highlights

No Survival Advantage for High-Dose Radiation Versus Standard-Dose Radiation in Stage III NSCLC

High-dose radiation was no better than standard-dose radiation given concurrently with chemotherapy in extending survival of patients with advanced unresectable NSCLC.

Oncology & Biotech News > Conference Highlights

Patients With Lung Cancer Often Receive Excess Radiation

Patients undergoing lung resection for NSCLC are frequently exposed to a higher dose of radiation than that which has been deemed safe for healthcare workers.

Oncology & Biotech News > Clinical Trial Reports

>>> Click here for more articles